Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours Β· Estimated delivery Aug 24 - Aug 29
Mounjaro is brand-name tirzepatide manufactured by Eli Lilly
For dual-indication patients, the primary diagnosis should match the brand prescribed
From nutritional counseling to exercise recommendations, we make sure that all of your weight-loss bases are covered
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile
US$ 23.37
US$ 25.78
US$ 22.91
US$ 28.62
US$ 20.37
US$ 22.24
US$ 20.82
US$ 22.30
